WO2002018944A3 - Mittel zur diagnose von tumoren - Google Patents
Mittel zur diagnose von tumoren Download PDFInfo
- Publication number
- WO2002018944A3 WO2002018944A3 PCT/EP2001/010020 EP0110020W WO0218944A3 WO 2002018944 A3 WO2002018944 A3 WO 2002018944A3 EP 0110020 W EP0110020 W EP 0110020W WO 0218944 A3 WO0218944 A3 WO 0218944A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tumours
- diagnosing
- diagnosing tumours
- dcoh
- interacts
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/362,843 US20040048317A1 (en) | 2000-08-30 | 2001-08-30 | Means for diagnosing tumours |
DE10193655T DE10193655D2 (de) | 2000-08-30 | 2001-08-30 | Mittel zur Diagnose von Tumoren |
AU2001289854A AU2001289854A1 (en) | 2000-08-30 | 2001-08-30 | Means for diagnosing tumours |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10042827A DE10042827A1 (de) | 2000-08-30 | 2000-08-30 | Mittel zur Diagnose von Tumoren |
DE10042827.4 | 2000-08-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002018944A2 WO2002018944A2 (de) | 2002-03-07 |
WO2002018944A3 true WO2002018944A3 (de) | 2003-03-20 |
Family
ID=7654456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/010020 WO2002018944A2 (de) | 2000-08-30 | 2001-08-30 | Mittel zur diagnose von tumoren |
Country Status (4)
Country | Link |
---|---|
US (1) | US20040048317A1 (de) |
AU (1) | AU2001289854A1 (de) |
DE (2) | DE10042827A1 (de) |
WO (1) | WO2002018944A2 (de) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5403712A (en) * | 1991-12-17 | 1995-04-04 | The Board Of Trustees Of The Leland Stanford Jr. University | Transcription cofactor assay |
-
2000
- 2000-08-30 DE DE10042827A patent/DE10042827A1/de not_active Withdrawn
-
2001
- 2001-08-30 WO PCT/EP2001/010020 patent/WO2002018944A2/de active Application Filing
- 2001-08-30 DE DE10193655T patent/DE10193655D2/de not_active Expired - Fee Related
- 2001-08-30 US US10/362,843 patent/US20040048317A1/en not_active Abandoned
- 2001-08-30 AU AU2001289854A patent/AU2001289854A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5403712A (en) * | 1991-12-17 | 1995-04-04 | The Board Of Trustees Of The Leland Stanford Jr. University | Transcription cofactor assay |
Non-Patent Citations (4)
Title |
---|
ESKINAZI RALLY ET AL: "Overexpression of pterin-4a-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 in human colon cancer.", AMERICAN JOURNAL OF PATHOLOGY, vol. 155, no. 4, October 1999 (1999-10-01), pages 1105 - 1113, XP002202374, ISSN: 0002-9440 * |
POGGE V STRANDMANN E ET AL: "ECTOPIC PIGMENTATION IN XENOPUS IN RESPONSE TO DCOH/PCD, THE COFACTOR OF HNF1 TRANSCRIPTION FACTOR/PTERIN-4 ALPHA-CARBINOLAMINE DEHYDRATASE", MECHANISMS OF DEVELOPMENT, ELSEVIER SCIENCE IRELAND LTD, IE, vol. 91, no. 1/2, 2000, pages 53 - 60, XP000946160, ISSN: 0925-4773 * |
STRANDMANN POGGE VAN E ET AL: "DEVELOPMENTAL EXPRESSION OF THE MATERNAL PROTEIN XDCOH, THE DIMERIZATION COFACTOR OF THE HOMEOPROTEIN LFB1 (HNF1)", DEVELOPMENT, COMPANY OF BIOLOGISTS, CAMBRIDGE,, GB, vol. 121, no. 4, 1995, pages 1217 - 1226, XP000946168, ISSN: 0950-1991 * |
V STRANDMANN ELKE POGGE ET AL: "Dimerization co-factor of hepatocyte nuclear factor 1/pterin-4alpha-carbinolamine dehydratase is necessary for pigmentation in Xenopus and overexpressed in primary human melanoma lesions.", AMERICAN JOURNAL OF PATHOLOGY, vol. 158, no. 6, June 2001 (2001-06-01), pages 2021 - 2029, XP002202375, ISSN: 0002-9440 * |
Also Published As
Publication number | Publication date |
---|---|
US20040048317A1 (en) | 2004-03-11 |
WO2002018944A2 (de) | 2002-03-07 |
DE10193655D2 (de) | 2003-07-17 |
DE10042827A1 (de) | 2002-03-14 |
AU2001289854A1 (en) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0009179D0 (en) | Non-invasive prenatal diagnosis | |
MXPA03001590A (es) | Anticuerpos para la il-1beta humana. | |
WO2002046477A3 (en) | Endogenous retroviruses up-regulated in prostate cancer | |
HK1030363A1 (en) | Noninvasive vaccination through the skin | |
WO2002080754A3 (en) | Methods for using annexin for detecting cell death in vivo and treating associated conditions | |
IT1316267B1 (it) | Innesto doppio, in particolare per autoveicolo. | |
MXPA03003820A (es) | Derivados de benzoxazinona, su preparacion y uso. | |
WO2002027315A3 (en) | Compounds with a branched linker | |
AU2003302165A8 (en) | Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof. | |
IL143739A0 (en) | Diagnostic assay | |
GB0016392D0 (en) | Skin diagnostic aid | |
ITRE990028A0 (it) | Integratore alimentare chelato ad uso agro-zootecnico, e metodo per l' ottenimento dello stesso. | |
WO2002066075A3 (en) | Biotin-derivatives and their conjugates with chelating agents | |
WO2002018944A3 (de) | Mittel zur diagnose von tumoren | |
WO2002024738A1 (en) | β-CATENIN NUCLEAR LOCALIZED PROTEIN | |
AU2002210438A1 (en) | Diagnosis of diseases which are associated with cd24 | |
MXPA03007634A (es) | Derivados de imidazolidina, su preparacion, su uso y preparaciones farmaceuticas que los contienen. | |
MXPA03006162A (es) | Derivados de mikanolida, su preparacion y sus usos terapeuticos. | |
AU2001293816A1 (en) | Tanning device, especially full body tanning device | |
IL145279A0 (en) | Antibodies against caspase-8, their preparation and use | |
IL161859A0 (en) | 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use | |
WO2000058506A3 (en) | Susceptibility to psoriasis | |
AU2002365104A8 (en) | Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof | |
IL155285A0 (en) | A polynucleotide encoding a human potassium channel alpha-subunit, methods for the preparation thereof and diagnostic methods utilizing the same | |
WO2000049134A8 (en) | Secreted proteins and polynucleotides encoding them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REF | Corresponds to |
Ref document number: 10193655 Country of ref document: DE Date of ref document: 20030717 Kind code of ref document: P |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10193655 Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10362843 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |